Related references
Note: Only part of the references are listed.Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?
Alyssa M. Peckham et al.
EXPERT OPINION ON DRUG SAFETY (2018)
Daily Opioid Use Fluctuates as a Function of Pain, Catastrophizing, and Affect in Patients With Sickle Cell Disease: An Electronic Daily Diary Analysis
Patrick H. Finan et al.
JOURNAL OF PAIN (2018)
All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population
Alyssa M. Peckham et al.
DRUG SAFETY (2018)
Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern?
Christopher W. Goodman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study
Tara Gomes et al.
PLOS MEDICINE (2017)
Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population
Alyssa M. Peckham et al.
CLINICAL DRUG INVESTIGATION (2017)
Abuse and Misuse of Pregabalin and Gabapentin
Kirk E. Evoy et al.
DRUGS (2017)
Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council
Roger Chou et al.
JOURNAL OF PAIN (2016)
Opioid Abuse in Chronic Pain - Misconceptions and Mitigation Strategies
Nora D. Volkow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Use of Opioid Analgesics following Common Upper Extremity Surgical Procedures: A National, Population-Based Study
Jennifer F. Waljee et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2016)
CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016
Deborah Dowell et al.
MMWR RECOMMENDATIONS AND REPORTS (2016)
Abuse of Gabapentin is Associated with Opioid Addiction
Leo Bastiaens et al.
PSYCHIATRIC QUARTERLY (2016)
Abuse and Diversion of Gabapentin Among Nonmedical Prescription Opioid Users in Appalachian Kentucky
Rachel V. Smith et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Prescription Medication Misuse Among Opioid Dependent Patients Seeking Inpatient Detoxification
Timothy Wilens et al.
AMERICAN JOURNAL ON ADDICTIONS (2015)
Profiles of pregabalin and gabapentin abuse by postmortem toxicology
Margareeta Hakkinen et al.
FORENSIC SCIENCE INTERNATIONAL (2014)
Risk of Adverse Health Outcomes with Increasing Duration and Regularity of Opioid Therapy
Leonard J. Paulozzi et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2014)
Gabapentinoid Abuse in Order to Potentiate the Effect of Methadone: A Survey among Substance Misusers
Colin R. W. Baird et al.
EUROPEAN ADDICTION RESEARCH (2014)
Retrospective cohort studies: advantages and disadvantages
Philip Sedgwick
BMJ-BRITISH MEDICAL JOURNAL (2014)
Pregabalin abuse among opiate addicted patients
Martin Grosshans et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Substance misuse of gabapentin
Blair H. Smith et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2012)
A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin
Howard N. Bockbrader et al.
CLINICAL PHARMACOKINETICS (2010)
Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use.
S. Swaroop Vedula et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Off-label prescribing among office-based physicians
David C. Radley et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Gabapentin abuse in inmates with prior history of cocaine dependence
L Reccoppa et al.
AMERICAN JOURNAL ON ADDICTIONS (2004)
Gabapentin: pharmacology and its use in pain management
MA Rose et al.
ANAESTHESIA (2002)
Share Paper
